(Q46105774)

English

Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial

scientific article published in February 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19249633

Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial (English)

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19249633

1 reference

based on heuristic

inferred from title

myocardial infarction

1 reference

based on heuristic

inferred from title

Eugene Braunwald

3

object named as

Eugene Braunwald

1 reference

Europe PubMed Central

19 December 2017

Gilles Montalescot

1

object named as

Gilles Montalescot

1 reference

Europe PubMed Central

19 December 2017

Elliott M Antman

7

object named as

Elliott M Antman

1 reference

Europe PubMed Central

19 December 2017

Carolyn F McCabe

6

object named as

Carolyn H McCabe

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19249633

Sabina A Murphy

4

object named as

Sabina A Murphy

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19249633

Stephen D Wiviott

2

object named as

Stephen D Wiviott

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19249633

author name string

C Michael Gibson

5

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19249633

TRITON-TIMI 38 investigators

8

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19249633

language of work or name

0 references

publication date

1 February 2009

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19249633

number of pages

9

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19249633

373

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19249633

723-731

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19249633

9665

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19249633

Sirolimus-eluting versus uncoated stents in acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960441-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960441-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Drug-eluting stents in acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960441-4

7 January 2021

based on heuristic

inferred from DOI database lookup

ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction—Executive Summary

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960441-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The full anticoagulation versus aspirin and ticlopidine (fantastic) study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960441-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960441-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized evaluation of anticoagulation versus antiplatelet therapy after coronary stent implantation in high-risk patients: the multicenter aspirin and ticlopidine trial after intracoronary stenting (MATTIS).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960441-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960441-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting : the clopidogrel aspirin stent international cooperative study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960441-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The second Euro Heart Survey on acute coronary syndromes: characteristics, treatment, and outcome of patients with ACS in Europe and the Mediterranean Basin in 2004

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960441-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960441-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960441-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960441-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myoc

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960441-4

7 January 2021

based on heuristic

inferred from DOI database lookup

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960441-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Prasugrel versus clopidogrel in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960441-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction. ReoPro and Primary PTCA Organization and Randomized Trial (RAPPORT) Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960441-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of glycoprotein IIb/IIIa receptor blockade with abciximab on clinical and angiographic restenosis rate after the placement of coronary stents following acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960441-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960441-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960441-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized trial comparing primary infarct artery stenting with or without abciximab in acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960441-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Stent thrombosis in randomized clinical trials of drug-eluting stents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960441-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a r

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960441-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Heart Disease and Stroke Statistics--2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960441-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Variable platelet response to aspirin and clopidogrel in atherothrombotic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960441-4

7 January 2021

based on heuristic

inferred from DOI database lookup

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960441-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Absorption, metabolization, and antiplatelet effects of 300-, 600-, and 900-mg loading doses of clopidogrel: results of the ISAR-CHOICE (Intracoronary Stenting and Antithrombotic Regimen: Choose Between 3 High Oral Doses for Immediate Clopidogrel Ef

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960441-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention: results from the ARMYDA-2 (Antiplatelet therapy for Reduction of MYocardial Damage during Angiop

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960441-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Clopidogrel loading dose (300 versus 600 mg) strategies for patients with stable angina pectoris subjected to percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960441-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of enoxaparin versus unfractionated heparin in patients with ST-segment elevation myocardial infarction also treated with clopidogrel

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960441-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of clopidogrel 600 mg administered pre-hospitally to improve primary percutaneous coronary intervention in patients with acute myocardial infarction (CIPAMI): study rationale and design

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960441-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Prasugrel achieves greater and faster P2Y12receptor-mediated platelet inhibition than clopidogrel due to more efficient generation of its active metabolite in aspirin-treated patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960441-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(09)60441-4

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19249633

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19249633

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46105774&oldid=2102801521"